RxDoctor Payments Data

Cristy Elving Dial, MD

Family Medicine · Jerseyville, ILNPI 1922056506

Payments from drug & device makers

$16,292in general payments, 2019–2025

Across 1,058 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$2K
  • Lilly USA, LLC$2K
  • Novo Nordisk$2K
  • AstraZeneca$1K
  • GSK$875
  • plus $6K from 46 others

What the payments were for

  • Food & beverage$16,17899%
  • Education$1141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,292 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$2,163
Medicare patients
62
Services billed
105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban359$160,913
OzempicSemaglutide121$156,319
MounjaroTirzepatide77$100,411
JardianceEmpagliflozin160$97,733
GemtesaVibegron213$97,204
FarxigaDapagliflozin Propanediol118$76,916
XareltoRivaroxaban125$69,223
Trelegy ElliptaFluticasone/Umeclidin/Vilanter74$67,345
RexultiBrexpiprazole32$57,423
JanuviaSitagliptin Phosphate68$32,920
TrulicityDulaglutide28$29,921
EntrestoSacubitril/Valsartan65$27,908
Aimovig AutoinjectorErenumab-Aooe24$26,163
LinzessLinaclotide36$24,501
ArexvyRsvpref3 Antigen/As01e/Pf72$22,362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$647$160,913359 claims
Novo NordiskOzempic$1,787$156,319121 claims
Lilly USA, LLCMounjaro, Trulicity$1,822$130,332105 claims
Boehringer IngelheimJardiance, Tradjenta$191$116,453194 claims
GSKTrelegy Ellipta, Arexvy, Anoro Ellipta$875$99,997164 claims
Sumitomo Pharma America, Inc.Gemtesa$182$97,204213 claims
AstraZenecaFarxiga$1,201$76,916118 claims
Johnson & JohnsonXarelto$555$69,223125 claims
Otsuka America Pharmaceutical, Inc.Rexulti$98$57,42332 claims
AbbVieLinzess, Vraylar$2,638$46,66549 claims
MerckJanuvia$421$32,92068 claims
NovartisEntresto$282$27,90865 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Jerseyville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →